Skip to main content
SpringerLink
Log in

Liposome associated interferon-alpha-2b functions as an anti-fibrogenic factor in dermal wounds in the guinea pig

  • Published:
Molecular and Cellular Biochemistry Aims and scope Submit manuscript

Abstract

We have previously reported that interferon-alpha-2b (IFN-α-2b) can be encapsulated in liposomes without compromising its anti-fibrogenic effects on dermal fibroblasts in vitro. This study was conducted to determine whether this preparation applied topically to guinea pig wounds can affect their healing. The rationale for this approach is that systemic administration of IFN-α-2b by injection for treatment of dermal fibrosis is uncomfortable, requires a large quantity of the cytokine and cannot be easily used in children. Liposomes are potentially useful vehicles for the topical delivery of drugs. Empty sonicated liposome vesicles were mixed with various concentrations of IFN-α-2b and then dried and rehydrated. An enzyme-linked immunosorbent assay (ELISA) was used to determine the efficiency of encapsulation and the stability of the preparation under experimental conditions. A total of 36 full thickness skin wounds (6/animal, 3 on each side) were made with an 8 mm disposable punch. Each wound on the right side received cream (100 mg/wound) containing 3000 units of liposome-encapsulated IFN-α-2b, while wounds on the left side received cream containing empty liposomes. There was a significant reduction in rate of contraction of wounds treated with IFN-α-2b as early as 5 days after wounding. This reduction remained significant up to 10 days. Northern analysis, used to evaluate the expression of mRNAs for type I and type III collagens in response to IFN-α-2b showed a marked reduction in abundance of the transcripts for the pro-α1(I) chain of type 1 collagen on days 11 and 14 after wounding. Similarly, the level of mRNA for type III procollagen was markedly reduced as early as day 7 and remained depressed up to day 14. These findings were consistent with results obtained for the total collagen content in tissue samples. Cellularity of the IFN-α-2b-treated wounds, assessed by vimentin content, was also markedly reduced at day 7 and remained depressed up to day 14. Liposome associated IFN-α-2b applied 5 days after completion of epithelialization reduced mRNA for the pro-α1(I) chain of type 1 collagen., confirming its transepidermal penetration and effectiveness. The activity of liposome-associated IFN-α-2b in vivo supports the concept of the topical use of this anti-fibrogenic agent for treatment of fibroproliferative disorders.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Scott PG, Ghahary A, Chambers M, Tredget EE: Biological basis of hypertrophic scarring. In: Advances in Structural Biology, vol. 3. 1994, pp 157–201

    Google Scholar 

  2. Rudolph R: Wide spread scars, hypertrophic scars and keloids. Clin Plast Surg 14: 253–260, 1987

    Google Scholar 

  3. Tredget EE, Shankowsky HA, Pannu R, Nedelec B, Iwashina T, Ghahary A, Taerum TV, Scott PG: Transforming growth factor-β in thermally injured patients with hypertrophic scars: Effects of interferon-α-2b. Plast Reconstr Surg 102: 1317–1328, 1998

    Google Scholar 

  4. Weiner N, Williams N, Birch G, Ramachandran C, Shipman C Jr, Flynn G: Topical delivery of liposomally encapsulated interferon evaluated in a cutaneous herpes guinea pig model. Antimicrob Agents Chemother 33: 1217–1221, 1989

    Google Scholar 

  5. Sen GC, Lengyel P: The interferon system. A bird's eye view of its biochemistry. J Biol Chem 267: 5017–5020, 1992

    Google Scholar 

  6. Tsutsumi Y, Kakumu S, Yoshioka K, Arao M, Inoue M, Wakita T: Effects of various cytokines on collagen synthesis by rat normal hepatocytes in primary cultures and fibroblasts. Digestion 44: 191–199, 1989

    Google Scholar 

  7. Tredget EE, Shen YJ, Liu G, Forsyth N, Smith C, Harrop RA, Scott PG, Ghahary A: Regulation of collagen synthesis and mRNA levels in normal and hypertrophic scar fibroblasts in vitro by interferon alpha-2b. Wound Rep Reg 1: 156–165, 1993

    Google Scholar 

  8. Harrop AR, Ghahary A, Scott PG, Forsyth N, Friedland A, Tredget EE: Regulation of collagen synthesis and mRNA expression in normal and hypertrophic scar fibroblasts in vitro by interferon-g. J Surg Res 58: 471–477, 1995

    Google Scholar 

  9. Rosenbloom J, Feldman G, Freundlich B, Jimenez SA: Transcriptional control of human diploid fibroblast collagen synthesis by gamma interferon. Biochem Biophys Res Commun 123: 365–372, 1984

    Google Scholar 

  10. Berman B, Duncan MR: Short-term keloid treatment in vivo with human interferon alfa-2b results in a selective and persistent normalization of keloidal fibroblast collagen, glycosaminoglycan and collagenase production in vitro. J Am Acad Dermatol 21: 694–702, 1989

    Google Scholar 

  11. Ghahary A, Shen YJ, Scott PG, Tredget EE: Expression of fibronectin mRNA in hypertrophic and normal dermal tissues and in vitro regulation by interferon alpha-2b. Wound Rep Reg 1: 166–174, 1993

    Google Scholar 

  12. Ghahary A, Shen YJ, Nedelec B, Scott PG, Tredget EE: Interferon gamma and alpha-2b differentially regulate the expression of collagenase and TIMP-1 mRNA in human hypertrophic and normal dermal fibroblasts. Wound Rep Reg 3: 13–21, 1995

    Google Scholar 

  13. Czaja MJ, Weiner FR, Eghbali M, Giambrone MA, Eghbali M, Zern MA: Differential effects of γ-interferon on collagen and fibronectin gene expression. J Biol Chem 262: 13348–13351, 1987

    Google Scholar 

  14. Veys EM, Mialants H, Verbruggen G, Grosclaude JP, Meyer W, Galazka A, Schindler J: Interferon gamma in rheumatoid arthritis — a double blind study comparing human recombinant interferon gamma with placebo.J Rheumatol 15:570–574, 1988

    Google Scholar 

  15. Jonas MM, Ragin L, Silva MO: Membranous glomerulonephritis and chronic persistent hepatitis B in a child: Treatment with recombinant interferon alpha. J Pediatr 119: 818–820, 1991

    Google Scholar 

  16. Castilla A, Prieto J, Fausto N: Transforming growth factors beta 1 and alpha in chronic liver disease. New Engl J Med 324: 933–940, 1991

    Google Scholar 

  17. Larrabee WF, East CA, Jaffe HF, Stephenson RN, Peterson KE: Intralesional interferon gamma treatment for keloid and hypertrophic scars. Arch Otolaryng Head Neck Surg 116: 1159–1162, 1990

    Google Scholar 

  18. Granstein RD, Rook A, Flotte TJ, Hass A, Gallo RL, Jaffe HF, Amento EP: A controlled trial of intralesional recombinant interferon-gamma in the treatment of keloidal scarring. Arch Dermatol 126: 1295–1302, 1990

    Google Scholar 

  19. Ghahary A, Shen Q, Rogers JA, Wang R, Fathi-Afshar A, Scott PG, Tredget EE: Liposome-associated interferon-α-2b functions as an antifibrogenic factor for human dermal fibroblasts. J Invest Dermatol 109: 55–60, 1997

    Google Scholar 

  20. Eppstein DA, Stewart WE: Binding and capture of human interferon alpha by reverse evaporation vesicles, multilamellar vesicles, and small unilamellar vesicles. J Interferon Res 1: 495–504, 1981

    Google Scholar 

  21. Traub P, Scherbarth A, Willingate-Theune J, Traub U: Large scale coisolation of vimentin and nuclear lamins from Ehrlich ascites tumor cells cultured in vitro. Prep Biochem 18: 381–404, 1988

    Google Scholar 

  22. Mechanic GL: Collagen biochemistry. In: D.J. Simmons, A.S. Kunin (eds). Skeletal Research. Academic Press, New York, 1979, pp 227–241.

    Google Scholar 

  23. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156–159, 1987

    Google Scholar 

  24. Stegemann H, Stalder K: Determination of hydroxyproline. Clin Chim Acta 18: 267–273, 1967

    Google Scholar 

  25. Nedelec B, Shen YJ, Ghahary A, Scott PG, Tredget EE: The effect of interferon alpha-2b on expression of cytoskeletal proteins in an in vitro model of wound contraction. J Lab Clin Med 126: 474–484, 1995

    Google Scholar 

  26. Dans MJ, Isseroff R: Inhibition of collagen lattice contraction by pentoxifylline and interferon-alpha-beta and-gamma. J Invest Dermatol 102: 118–121, 1994

    Google Scholar 

  27. Catty RHC: Healing and contraction of experimental full thickness wounds in the human. Brit J Surg 52: 542–548, 1965

    Google Scholar 

  28. Eppstein DA, Stewart WE: Altered pharmacological properties of liposome-associated human interferon-alpha. J Virol 41: 575–582, 1982

    Google Scholar 

  29. Giometto B, Miotto D, Botteri M, Alessio L, Scanarini M, An SF, Tavolato B: Follicula-Stellate cells of human pituitary adenomas: Immunohistochemical study of the monocyte/macrophage phenotype expression. Neuroendocrinology 65: 47–52, 1997

    Google Scholar 

  30. Mezei M, Gulasekharam V: Liposomes — a selective drug delivery system for the topical route of administration: Lotion dosage form. Life Sci 26: 1473–1477, 1980

    Google Scholar 

  31. Lasch J, Wohlrab W: Liposome-bound cortisol: A new approach to cutaneous therapy. Biomed Biochem Acta 45: 1295–1299, 1986

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, Wound Healing Research Group, University of Alberta, Edmonton, Alberta, Canada, T6G 2B7

    Aziz Ghahary, Edward E. Tredget, Qiong Shen, Ruhangiz T. Kilani & Masaki Takeuchi

  2. Department of Biochemistry, University of Alberta, Edmonton, Alberta, Canada, T6G 2B7

    Paul G. Scott

Authors
  1. Aziz Ghahary
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Edward E. Tredget
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Qiong Shen
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ruhangiz T. Kilani
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Paul G. Scott
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Masaki Takeuchi
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ghahary, A., Tredget, E.E., Shen, Q. et al. Liposome associated interferon-alpha-2b functions as an anti-fibrogenic factor in dermal wounds in the guinea pig. Mol Cell Biochem 208, 129–137 (2000). https://doi.org/10.1023/A:1007054424400

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1007054424400

Search

Navigation